Dabrowska B, Krasnodebski I W, Tadeusiak W
Katedry i Kliniki Chirurgii Gastroenterologicznej Instytutu Chirurgii AM, Warszawie.
Pol Tyg Lek. 1991;46(45-47):890-1.
Tumor markers known to date are not sensitive and specific enough to detect malignant tumors. Therefore, attempts to find new markers have led to sialic acid assays in cancer patients. Serum sialic acid, CEA and ESR have been determined in 33 patients with the cancer of the colon. All patients have been divided into four groups, according to TNM cancer staging. Serum sialic acid levels have been increased by 100% of patients in groups I and IV. The most significant correlation was noted between sialic acid levels and ESR. No significant relationship between serum sialic acid and CEA have been noted. No correlation of the colon cancer stage, according to TNM staging, and sialic acid and CEA levels in the peripheral blood has been observed. It seems, however, that serum sialic acid assay may be useful auxiliary technique in the detection and monitoring of patients with colon cancer.
目前已知的肿瘤标志物对于检测恶性肿瘤而言,敏感度和特异性都不够高。因此,寻找新标志物的尝试促使人们对癌症患者进行唾液酸检测。对33例结肠癌患者测定了血清唾液酸、癌胚抗原(CEA)和红细胞沉降率(ESR)。根据TNM癌症分期系统,所有患者被分为四组。第一组和第四组中各有100%的患者血清唾液酸水平升高。唾液酸水平与ESR之间存在最显著的相关性。未发现血清唾液酸与CEA之间存在显著关系。未观察到根据TNM分期的结肠癌分期与外周血中唾液酸和CEA水平之间存在相关性。然而,血清唾液酸检测似乎可能是检测和监测结肠癌患者的一种有用辅助技术。